Tissue Regenix Group (LSE:TRX) Change In Receivables : £0.85 Mil (TTM As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Tissue Regenix Group Change In Receivables?

Tissue Regenix Group's change in receivables for the quarter that ended in Dec. 2023 was £1.27 Mil. It means Tissue Regenix Group's Accounts Receivable declined by £1.27 Mil from Jun. 2023 to Dec. 2023 .

Tissue Regenix Group's change in receivables for the fiscal year that ended in Dec. 2023 was £0.85 Mil. It means Tissue Regenix Group's Accounts Receivable declined by £0.85 Mil from Dec. 2022 to Dec. 2023 .

Tissue Regenix Group's Accounts Receivable for the quarter that ended in Dec. 2023 was £2.39 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Tissue Regenix Group's Days Sales Outstanding for the six months ended in Dec. 2023 was 35.88.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Tissue Regenix Group's liquidation value for the six months ended in Dec. 2023 was £-1.41 Mil.

Tissue Regenix Group Change In Receivables Historical Data

The historical data trend for Tissue Regenix Group's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tissue Regenix Group Change In Receivables Chart

Tissue Regenix Group Annual Data

Trend

Jan14

Jan15

Jan16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

1.08

-0.19

-0.39

-0.58

0.85

Tissue Regenix Group Semi-Annual Data
	Jan14	Jul14	Jan15	Jul15	Jan16	Jul16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Receivables	Get a 7-Day Free Trial															-0.42	0.07	-0.64	-0.43	1.27

Tissue Regenix Group Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.85 Mil.

Tissue Regenix Group (LSE:TRX) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Tissue Regenix Group's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	2.391	/	12.162	*	91
=	35.88

2. In Ben Graham's calculation of liquidation value, Tissue Regenix Group's accounts receivable are only considered to be worth 75% of book value:

Tissue Regenix Group's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	3.674	-	10.972	+	0.75 * 2.391	+	0.5 * 8.183
=	-1.41

Tissue Regenix Group Change In Receivables Related Terms

Thank you for viewing the detailed overview of Tissue Regenix Group's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Tissue Regenix Group (LSE:TRX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tissue Regenix Group PLC (LSE:TRX) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

LSW:Germany

Address

Lotherton Way, Unit 3, Phoenix Court, Garforth, GBR, LS25 2GY

Website

https://www.tissueregenix.com

Tissue Regenix Group PLC is a pioneering medical technology company engaged in the development of regenerative products. The company incorporates dCELL and BioRinse technology, which helps to address complex and varying clinical needs. Its product portfolio includes Biosurgery, Orthopaedics, and Dental. The company has operations around the world, with special emphasis in the United States.